HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 364 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $912 | +14.6% | 23,869 | +8.2% | 0.01% | +25.0% |
| Q2 2023 | $796 | -92.3% | 22,069 | -91.9% | 0.00% | -93.3% |
| Q1 2023 | $10,390 | +783.5% | 272,069 | +1216.3% | 0.06% | +757.1% |
| Q4 2022 | $1,176 | -99.9% | 20,669 | 0.0% | 0.01% | +40.0% |
| Q3 2022 | $817,000 | -10.1% | 20,669 | 0.0% | 0.01% | -16.7% |
| Q2 2022 | $909,000 | -3.3% | 20,669 | -12.3% | 0.01% | +20.0% |
| Q1 2022 | $940,000 | -17.9% | 23,569 | -17.2% | 0.01% | -16.7% |
| Q4 2021 | $1,145,000 | -1.1% | 28,469 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $1,158,000 | -10.4% | 28,469 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $1,293,000 | +32.2% | 28,469 | +21.3% | 0.01% | +16.7% |
| Q1 2021 | $978,000 | -25.1% | 23,469 | -23.2% | 0.01% | -25.0% |
| Q4 2020 | $1,306,000 | +21.9% | 30,569 | -25.0% | 0.01% | 0.0% |
| Q3 2020 | $1,071,000 | -51.0% | 40,769 | -50.0% | 0.01% | -11.1% |
| Q2 2020 | $2,186,000 | – | 81,538 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |